Blood pressure-lowering treatment in patients with type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) and heart disease events and improved mortality, revealed a study by George Institute for Global Health, University of Oxford, Oxford, U.K. The authors suggested that the findings support the use of medications for BP lowering in patients with type 2 diabetes.
Type 2 diabetes is associated with a substantially increased risk of heart attack and stroke, and by 2030, it is estimated that there will be at least 400 million individuals with type 2 diabetes mellitus worldwide. Blood pressure (BP) levels are on average higher among individuals with diabetes and increased BP is a risk factor for people with diabetes.
Researchers conducted a review and meta-analysis of large-scale randomized controlled trials of BP-lowering treatment including patients with diabetes, published between January 1966 and October 2014. Researchers found that each 10-mm Hg lower systolic BP was associated with a lower risk of mortality, cardiovascular disease events, coronary heart disease events, stroke, albuminuria (the presence of excessive protein in the urine), and retinopathy (loss of vision related to diabetes).